Esperion Therapeutics, Inc. (ESPR) Stock Price History
Historical prices from 2013 to 2026
Loading 10-year price history...
ESPR Historical Performance
Short-Term Returns
ESPR Stock Price Trajectory (2013–2026)
As of May 8, 2026, Esperion Therapeutics, Inc. (ESPR) trades at $3.14, representing a +260.5% return over the past year. The stock has delivered a -85.9% total return over five years (-32.4% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $120.96 on May 21, 2015. From this peak, ESPR has corrected -97.4%, currently trading 11% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers MDGL (+79.0% 1Y), EWTX (+145.0% 1Y), and PRTA (+44.4% 1Y), ESPR has outperformed the peer group average. Compare ESPR vs MDGL →
ESPR Historical Price Data (2025–2026)
Showing 30 of 3,237 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 3.15 | 3.15 | 3.13 | 3.14 | 19.32M | -0.32% |
| 2026-05-06 | 3.12 | 3.18 | 3.11 | 3.15 | 23.74M | +1.19% |
| 2026-05-05 | 3.12 | 3.12 | 3.11 | 3.11 | 25.60M | -0.22% |
| 2026-05-04 | 3.10 | 3.12 | 3.10 | 3.12 | 34.30M | +0.32% |
| 2026-05-01 | 3.13 | 3.14 | 3.10 | 3.11 | 182.01M | +55.50% |
| 2026-04-30 | 1.93 | 2.04 | 1.89 | 2.00 | 4.77M | +4.71% |
| 2026-04-29 | 1.91 | 1.92 | 1.80 | 1.91 | 5.64M | 0.00% |
| 2026-04-28 | 1.95 | 2.02 | 1.89 | 1.91 | 6.32M | 0.00% |
| 2026-04-27 | 1.91 | 2.04 | 1.88 | 1.91 | 7.07M | 0.00% |
| 2026-04-24 | 1.96 | 1.96 | 1.81 | 1.91 | 6.96M | 0.00% |
| 2026-04-23 | 1.98 | 2.00 | 1.91 | 1.91 | 4.18M | -3.05% |
| 2026-04-22 | 1.93 | 2.01 | 1.89 | 1.97 | 9.66M | +3.14% |
| 2026-04-21 | 2.02 | 2.03 | 1.87 | 1.91 | 12.02M | -5.45% |
| 2026-04-20 | 2.04 | 2.04 | 1.96 | 2.02 | 5.42M | -0.98% |
| 2026-04-17 | 2.11 | 2.15 | 2.02 | 2.04 | 6.58M | -0.49% |
| 2026-04-16 | 2.19 | 2.21 | 2.03 | 2.05 | 7.78M | -5.53% |
| 2026-04-15 | 2.05 | 2.17 | 2.04 | 2.17 | 16.33M | +5.85% |
| 2026-04-14 | 2.24 | 2.27 | 2.03 | 2.05 | 7.75M | -7.66% |
| 2026-04-13 | 2.16 | 2.25 | 2.10 | 2.22 | 5.82M | +2.30% |
| 2026-04-10 | 2.19 | 2.24 | 2.07 | 2.17 | 10.57M | -0.46% |
| 2026-04-09 | 2.29 | 2.33 | 2.18 | 2.18 | 8.17M | -6.44% |
| 2026-04-08 | 2.44 | 2.46 | 2.28 | 2.33 | 4.29M | +0.87% |
| 2026-04-07 | 2.51 | 2.52 | 2.19 | 2.31 | 9.20M | -9.41% |
| 2026-04-06 | 2.62 | 2.77 | 2.52 | 2.55 | 9.76M | -2.30% |
| 2026-04-02 | 2.56 | 2.65 | 2.52 | 2.61 | 5.74M | 0.00% |
| 2026-04-01 | 2.77 | 2.78 | 2.59 | 2.61 | 7.03M | -4.74% |
| 2026-03-31 | 2.71 | 2.91 | 2.69 | 2.74 | 7.30M | +4.18% |
| 2026-03-30 | 2.74 | 2.86 | 2.54 | 2.63 | 6.35M | -4.01% |
| 2026-03-27 | 2.82 | 2.84 | 2.73 | 2.74 | 2.32M | -3.86% |
| 2026-03-26 | 2.71 | 2.89 | 2.66 | 2.85 | 3.95M | +3.26% |
See ESPR's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ESPR Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ESPR vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonESPR — Frequently Asked Questions
Quick answers to the most common questions about buying ESPR stock.
How has ESPR stock performed recently?
ESPR returned +260.5% over the past year, beating its 5-year annualized CAGR of -32.4%. The stock trades above its 200-day moving average, confirming the uptrend.
What is ESPR's all-time high price?
Esperion Therapeutics, Inc. reached $120.96 on 2015-05-21. The 52-week high is $4.18. Current 1-year return of +260.5% places the stock closer to historical peaks.
Where can I download ESPR historical price data?
This page provides ESPR daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2013-2026, downloadable in CSV format.